{
    "clinical_study": {
        "@rank": "46950", 
        "arm_group": {
            "arm_group_label": "Pediatric NAFLD Cohort", 
            "description": "Overweight and obese children and adolescents at risk for non alcoholic fatty liver disease will undergo oral glucose tolerance testing (ogtt), genotyping, abdominal and liver magnetic resonance imaging (mri), and will provide a stool sample at baseline and at 2 year follow up. A small subset will undergo liver biopsy to test for hepatic steatosis and nonalcoholic steatohepatitis."
        }, 
        "biospec_descr": {
            "textblock": "Serum"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This is a study to investigate genetic predisposition to hepatic steatosis and the\n      expression of gluconeogenic and lipogenic genes in livers of obese children and adolescents.\n\n      Hypothesis 1: Common variants recently associated with variation in plasma TG levels\n      identified in Genome Wide Association Studies (GWAS) (such as GCKR, PNPLA3) can affect\n      accumulation of fat and subsequent development of Non Alcoholic Fatty Liver Disease (NAFLD).\n      Gene variants act in additive or synergistic manner with progressive liver fat accumulation\n      per additional risk allele.\n\n      Hypothesis 2: With increase in hepatic fat content NASH and fibrosis will increase.\n      Furthermore, expression of lipogenic markers (SREBP1c) will increase."
        }, 
        "brief_title": "Genetics of Fatty Liver Disease in Children", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Non Alcoholic Fatty Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Fatty Liver", 
                "Liver Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "To establish a cohort of obese youths to prospectively analyze potential factors (genetic\n      and nutritional factors) that might affect the expression and progression of NAFLD. This\n      study will determine genetic markers and their ability to convey susceptibility to NAFLD in\n      obese children and adolescents. Furthermore, potential mechanisms that might contribute to\n      the accumulation of hepatic Triglyceride (TG) accumulation will be, for the first time,\n      assessed by genotyping. Additionally, we will examine the presence of intestinal microbiome\n      in the development of fatty liver through stool collection."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  between 7 and 18 years of age,\n\n          -  overweight or obese with a BMI greater than the 85th percentile for age and gender,\n             and\n\n          -  be otherwise healthy.\n\n        Exclusion Criteria:\n\n          -  the use of any medication that alters liver function, blood pressure, glucose or\n             lipid metabolism and\n\n          -  no use of any antipsychotic medication\n\n          -  Youth on chronic anti-inflammatory medications or who consume alcohol are also\n             excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "7 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The majority of the research subjects will be recruited from the Yale Pediatric Obesity\n        Clinic and the Endocrine Clinic."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01966627", 
            "org_study_id": "1104008388", 
            "secondary_id": "R01HD040787"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pediatric NAFLD Cohort", 
                "description": "oral glucose tolerance test", 
                "intervention_name": "ogtt", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Pediatric NAFLD Cohort", 
                "description": "genotyping to look for risk alleles", 
                "intervention_name": "genotyping", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Pediatric NAFLD Cohort", 
                "description": "magnetic resonance imaging scan of abdomen and liver - abdominal and liver mri", 
                "intervention_name": "abdominal and liver magnetic resonance imaging", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Pediatric NAFLD Cohort", 
                "description": "stool sample taken to investigate metabolites", 
                "intervention_name": "stool sample", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Pediatric NAFLD Cohort", 
                "description": "liver biopsy to examine for cellular change and steatosis", 
                "intervention_name": "liver biopsy", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Liver Extracts"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "non alcoholic fatty liver", 
            "childhood obesity", 
            "genetic variants"
        ], 
        "lastchanged_date": "October 16, 2013", 
        "location": {
            "contact": {
                "last_name": "Bridget Pierpont, M.A.", 
                "phone": "203-785-2942"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06510"
                }, 
                "name": "Yale University"
            }, 
            "investigator": {
                "last_name": "Sonia Caprio, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Genetics of Fatty Liver Disease in Childhood Obesity.", 
        "other_outcome": [
            {
                "description": "Measure microbiota diversity via stool samples to understand variance of triglycerides accumulation in liver", 
                "measure": "DNA gene sequencing of intestinal bacteria's", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Use liver biopsy specimen to assess differences in gene expression, as well as inflammation.", 
                "safety_issue": "No", 
                "time_frame": "As indicated by Pediatric Hepatolgist"
            }
        ], 
        "overall_contact": {
            "email": "melissa.m.shaw@yale.edu", 
            "last_name": "Melissa Shaw, B.A.", 
            "phone": "203-785-6459"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Sonia Caprio, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "gene mutation allele variation identification measure via gene extraction", 
            "measure": "gene expression", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "reference": {
            "PMID": "16912127", 
            "citation": "Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006 Nov;91(11):4287-94. Epub 2006 Aug 15."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01966627"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Sonia Caprio", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Abdominal MRI to measure liver fat and subcutaneous and visceral fat ratio done at baseline and 2 year follow up", 
                "measure": "hepatic fat content", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "glucose tolerance status measured by 3 hour oral glucose tolerance test done at baseline and 2 year follow up", 
                "measure": "glucose tolerance", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Yale University", 
        "sponsors": {
            "collaborator": {
                "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}